Folate and choline metabolism gene variants in relation to ovarian cancer risk in the polish population

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5553-5560

  Pawlik, Piotr ^a   Mostowska, Adrianna ^a   Lianeri, Margarita ^a   Sajdak, Stefan ^a   Kędzia, Helena ^a   Jagodzinski, Paweł P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Choline; Folate metabolism; Ovarian cancer; Polymorphism

Indexed keywords

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETAINE HOMOCYSTEINE METHYLTRANSFERASE; CADHERIN; CADHERIN 13; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; TRANSCOBALAMIN II; UNCLASSIFIED DRUG; CHOLINE; FOLIC ACID; H CADHERIN; H-CADHERIN;

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE GENE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE GENE; ADULT; ALLELE; ARTICLE; BETAINE HOMOCYSTEINE METHYLTRANSFERASE GENE; CADHERIN 13 GENE; CANCER INCIDENCE; CANCER RISK; CHOLINE METABOLISM; CONTROLLED STUDY; DNA METHYLATION; ETHNIC GROUP; FEMALE; FOLATE METABOLISM; GENE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METABOLISM; METHIONINE SYNTHASE REDUCTASE GENE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE GENE; MULTIFACTOR DIMENSIONALITY REDUCTION; OVARY CANCER; POLISH; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCOBALAMIN II GENE; CASE CONTROL STUDY; GENETIC DATABASE; GENETIC EPISTASIS; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MIDDLE AGED; OVARY TUMOR; POLAND; RISK FACTOR; TUMOR GENE;

CADHERINS; CASE-CONTROL STUDIES; CHOLINE; DATABASES, GENETIC; DNA METHYLATION; EPISTASIS, GENETIC; FEMALE; FOLIC ACID; GENE FREQUENCY; GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; OVARIAN NEOPLASMS; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84863736217     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1359-0     Document Type: Article

References (61)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 20 0 6. Ann Oncol 18:581-592
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 20 0 8. CA Cancer J Clin 58:71-96
3. Sueblinvong T, Carney ME (2009) Current understanding of risk factors for ovarian cancer. Curr Treat Options Oncol 10:67-81
4. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683-692
5. Balch C, Huang TH, Brown R, Nephew KP (2004) The epigenetics of ovarian cancer drug resistance and resensitization. Am J Obstet Gynecol 191:1552-1572
6. Barton CA, Hacker NF, Clark SJ, O'Brien PM (2008) DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment. Gynecol Oncol 109:129-139
7. Balch C, Fang F, Matei DE, Huang TH, Nephew KP (2009) Epigenetic changes in ovarian. Cancer Endocrinol 150:4003-4011
8. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358: 1148-1159
9. Schickel R, Boyerinas B, Park SM, Peter ME (2008) MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27:5959-5974
10. Turek-Plewa J, Jagodziński PP (2005) The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 10:631-647
11. Cantoni GL (1953) S-adenosylmethionine; a new intermediate fordem enzymatically from L-methionine and adenosinetriphosphate. J Biol Chem 204:403-416
12. Li YN, Gulati S, Baker PJ, Brody LC, Banerjee R, Kruger WD (1996) Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet 5:851-858
13. Garrow TA (1996) Purification, kinetic properties, and cDNA cloning of mammalian betaine-homocysteine methyltransferase. J Biol Chem 271:22831-22838
14. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 10:111-113
15. Hum DW, Bell AW, Rozen R, MacKenzie RE (1988) Primary structure of a human trifunctional enzyme: isolation of a cDNA encoding methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate- cyclohydrolase, formyltetrahydrofolate synthetase. J Biol Chem 263:15946-15950
16. Hakami N, Neiman PE, Canellos GP, Lazerson J (1971) Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings. New Eng J Med 285:1163-1170
17. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, Heng HH, Rommens JM, Scherer SW, Rosenblatt DS, Gravel RA (1998) Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 95:3059-3064
18. Paz MF, Avila S, Fraga MF, Pollan M, Capella G, Peinado MA, Sanchez-Cespedes M, Herman JG, Esteller M (2002) Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 62:4519-4524
19. Hazra A, Fuchs CS, Kawasaki T, Kirkner GJ, Hunter DJ, Ogino S (2010) Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer. Cancer Causes Control 21:331-345
20. Kang S, Kim JW, Kang GH, Park NH, Song YS, Kang SB, Lee HP (2005) Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 96:173-180
21. Liu H, Jin G, Wang H,WuW, Liu Y, Qian J, Fan W, Ma H, Miao R, Hu Z, Sun W, Wang Y, Jin L, Wei Q, Shen H, Huang W, Lu D (2008) Association of polymorphisms in one-carbon metabolizing genes and lung cancer risk: a case-control study in Chinese population. Lung Cancer 61:21-29
22. Hazra A, Wu K, Kraft P, Fuchs CS, Giovannucci EL, Hunter DJ (2007) Twenty-four non-synonymous polymorphisms in the onecarbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study. Carcinogenesis 28:1510-1519
23. Xu X, Gammon MD, Wetmur JG, Bradshaw PT, Teitelbaum SL, Neugut AI, Santella RM, Chen J (2008) B-vitamin intake, onecarbon metabolism, and survival in a population-based study of women with breast cancer. Cancer Epidemiol Biomark Prev 17:2109-2116
24. Suzuki T, Matsuo K, Hasegawa Y, Hiraki A, Wakai K, Hirose K, Saito T, Sato S, Ueda R, Tajima K (2007) One-carbon metabolism- related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study. Cancer Sci 98: 1439-1446
25. Suzuki T, Matsuo K, Hiraki A, Saito T, Sato S, Yatabe Y, Mitsudomi T, Hida T, Ueda R, Tajima K (2007) Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. Carcinogenesis 28:1718-1725
26. Wu Q, Lothe RA, Ahlquist T, Silins I, Tropé CG, Micci F, Nesland JM, Suo Z, Lind GE (2007) DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets. Mol Cancer 6:45
27. Bol GM, Suijkerbuijk KP, Bart J, Vooijs M, van der Wall E, van Diest PJ (2010) Methylation profiles of hereditary and sporadic ovarian cancer. Histopathology 57:363-370
28. Cho KR, Shih IM (2009) Ovarian cancer. Annu Rev Pathol 4:287-313
29. Bast RC Jr, Hennessy B, Mills GB (2009) The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9: 415-428
30. Fasching PA, Gayther S, Pearce L, Schildkraut JM, Goode E, Thiel F, Chenevix-Trench G, Chang-Claude J, Wang-Gohrke S, Ramus S, Pharoah P, Berchuck A; OCAC (Ovarian Cancer Association Consortium) (2009) Role of genetic polymorphisms and ovarian cancer susceptibility Mol Oncol 3:171-181
31. Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7:21-33
32. Sharma S, Kelly TK, Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31:27-36
33. Kwon MJ, Shin YK (2011) Epigenetic regulation of cancerassociated genes in ovarian cancer. Int J Mol Sci 12:983-1008
34. Kotsopoulos J, Hankinson SE, Tworoger SS (2010) Dietary betaine and choline intake are not associated with risk of epithelial ovarian cancer. Eur J Clin Nutr 64:111-114
35. Mostowska A, Myka M, Lianeri M, Roszak A, Jagodziński PP (2011) Folate and choline metabolism gene variants and development of uterine cervical carcinoma. Clin Biochem 44:596-600
36. Xu X, Gammon MD, Zeisel SH, Bradshaw PT, Wetmur JG, Teitelbaum SL, Neugut AI, Santella RM, Chen J (2009) High intakes of choline and betaine reduce breast cancer mortality in a population-based study. FASEB J 23:4022-4028
37. Kelemen LE, Sellers TA, Schildkraut JM, Cunningham JM, Vierkant RA, Pankratz VS, Fredericksen ZS, Gadre MK, Rider DN, Liebow M, Goode EL (2008) Genetic variation in the onecarbon transfer pathway and ovarian cancer risk. Cancer Res 68:2498-2506
38. Kotsopoulos J, Hecht JL, Marotti JD, Kelemen LE, Tworoger SS (2010) Relationship between dietary and supplemental intake of folate, methionine, vitamin B6 and folate receptor alpha expression in ovarian tumors. Int J Cancer 126:2191-2198
39. Silva LM, Silva JN, Galbiatti AL, Succi M, Ruiz MT, Raposo LS, Maniglia JV, Pavarino-Bertelli EC, Goloni-Bertollo EM (2011) Head and neck carconogenesis: impact of MTHFD1 G1958A polymorphism. Rev Assoc Med Bras 57:194-199
40. Krajinovic M, Lemieux-Blanchard E, Chiasson S, Primeau M, Costea I, Moghrabi A (2004) Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics J 4:66-72
41. Zhang Z, Shi Q, Liu Z, Sturgis EM, Spitz MR, Wei Q (2005) Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol Biomark Prev 14:1188-1193
42. Ma E, Iwasaki M, Junko I, Hamada GS, Nishimoto IN, Carvalho SM, Motola J Jr, Laginha FM, Tsugane S (2009) Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC Cancer 9:122
43. Matsuo K, Ito H, Wakai K, Hirose K, Saito T, Suzuki T, Kato T, Hirai T, Kanemitsu Y, Hamajima H, Tajima K (2005) One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis 26:2164-2171
44. de Lima EL, da Silva VC, da Silva HD, Bezerra AM, de Morais VL, de Morais AL, Cruz RV, Barros MH, Hassan R, de Freitas AC, Muniz MT (2010) MTR polymorphic variant A2756G and retinoblastoma risk in Brazilian children. Pediatr Blood Cancer 54:904-908
45. Lima CS, Ortega MM, Ozelo MC, Araujo RC, De Souza CA, Lorand-Metze I, Annichino-Bizzacchi JM, Costa FF (2008) Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Leuk Res 32:401-405
46. Skibola CF, Forrest MS, Coppedé F, Agana L, Hubbard A, Smith MT, Bracci PM, Holly EA (2004) Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 104:2155-2162
47. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, Taylor PR, Mark SD (2003) Esophageal and gastric cardia cancer risk and folate-and vitamin B(12)- related polymorphisms in Linxian, China. Cancer Epidemiol Biomark Prev 12:1222-1226
48. Bethke L, Webb E, Murray A, Schoemaker M, Feychting M, Lönn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Swerdlow A, Houlston R (2008) Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomark Prev 17:1195-1202
49. Matsuo K, Hamajima N, Hirai T, Kato T, Inoue M, Takezaki T, Tajima K (2002) Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer. Asian Pac J Cancer Prev 3:353-359
50. Suzuki T, Matsuo K, Sawaki A, Mizuno N, Hiraki A, Kawase T, Watanabe M, Nakamura T, Yamao K, Tajima K, Tanaka H (2008) Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 17:2742-2747
51. Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, Yamashita T, Iwata H, Tajima K (2008) One-carbon metabolism- related gene polymorphisms and risk of breast cancer. Carcinogenesis 29:356-362
52. Gershoni-Baruch R, Dagan E, Israeli D, Kasinetz L, Kadouri E, Friedman E (2000) Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur J Cancer 36:2313-2316
53. Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Edler L, Lubiński J, Scott RJ, Hamann U (2007) Methylenetetrahydrofolate reductase polymorphisms modify BRCA1- associated breast and ovarian cancer risks. Breast Cancer Res Treat 104:299-308
54. Terry KL, Tworoger SS, Goode EL, Gates MA, Titus-Ernstoff L, Kelemen LE, Sellers TA, Hankinson SE, Cramer DW (2010) MTHFR polymorphisms in relation to ovarian cancer risk. Gynecol Oncol 119:319-324
55. Neumann AS, Lyons HJ, Shen H, Liu Z, Shi Q, Sturgis EM, Shete S, Spitz MR, El-Naggar A, Hong WK, Wei Q (2005) Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer 115:131-136
56. Liu YX, Wang B, Wan MH, Tang WF, Huang FK, Li C (2011) Meta-analysis of the relationship between the metholenetetrahydrofolate reductase C677T genetic polymorphism, folate intake and esophageal cancer. Asian Pac J Cancer Prev 12:247-252
57. Arslan S, Karadayi S, Yildirim ME, Ozdemir O, Akkurt I (2011) The association between methylene-tetrahydrofolate reductase gene polymorphism and lung cancer risk. Mol Biol Rep 38:991-996
58. Maruti SS, Ulrich CM, Jupe ER, White E (2009) MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study. Breast Cancer Res 11:R91
59. Lacasaña-Navarro M, Galván-Portillo M, Chen J, López-Cervantes M, López-Carrillo L (2006) Methylenetetrahydrofolate reductase 677C[T polymorphism and gastric cancer susceptibility in Mexico. Eur J Cancer 42:528-533
60. Iacopetta B, Heyworth J, Girschik J, Grieu F, Clayforth C, Fritschi L (2009) The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer. Int J Cancer 125:84-90
61. Sood S, Das R, Trehan A, Ahluwalia J, Sachdeva MU, Varma N, Bansal D, Marwaha RK (2010) Methylenetetrahydrofolate reductase gene polymorphisms: association with risk for pediatric acute lymphoblastic leukemia in north Indians. Leuk Lymphoma 51:928-932